Seeking an explanation over the trials of Patanjali drug done in NIMS, the Rajasthan Health Department served notice to NIMS. The Patanjali drug ‘Colonil’ claims to cure COVID-19 patients within 7 days.
Further, Patanjali claimed that their medicine showed 100 per cent positive results in clinical trials. However, they said that their test result was not for patients on a life support system.
As per reports, the trials for controversial “Coronil’ drug were conducted at NIMS, Jaipur before it’s launching.
PTI reported what Dr Narottam Sharma told, “We served notice to the hospital on Wednesday evening seeking explanation in three days. The hospital did not inform the state government nor sought permission.”
Dr Narottam Sharma is CMO and Health officer in Jaipur.
However, now NIMS has distanced itself from the drug. It denied any clinical trials of ‘Colonil‘ done at the hospital.
NIMS Chairman, Dr. B.S. Tomar told The New Indian Express that there was no serious case in the patients admitted at the hospital.
“Only 100 asymptomatic patients were given few Ayurvedic medicines under the sponsorship of Patanjali. But we did not prepare any medicine nor did we know its name,” he reportedly said.
Dr. B.S Tomar reportedly claims that he had the ICMR’s trial wing, the Clinical Trials Registry – India’s permission for five ayurvedic medicines to be tested on coronavirus patients.
Earlier the Ayush Ministry has asked Patanjali Ayurved for stopping any further advertising and claiming of their medicine.
Mr Hashmi said that the Ayush Ministry did not get any composition details of the ayurvedic medicine, earlier reported by The Wire.
While the Uttarakhand government has served a notice to Patanjali for its claims about the drug, the states of Rajasthan and Maharashtra have reportedly refused to allow the Patanjali product to be used in their respective states till it received clearance from the AYUSH ministry.